A Cancer Research UK multicenter randomized phase II study of induction chemotherapy followed by gemcitabine- or capecitabine-based chemoradiotherapy for locally advanced nonmetastatic pancreatic cancer

被引：1
|
作者：
Mukherjee, S.
Hurt, C.
Griffiths, G.
Crosby, T.
Staffurth, J.
Bridges, S.
Bridgewater, J. A.
Mcdonald, A.
Falk, S.
Maughan, T. S.
机构：
[1] Northampton Gen Hosp, Northampton, England
[2] Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales
[3] Cardiff Univ, Wales Canc Trials Unit, Cardiff CF10 3AX, S Glam, Wales
[4] Velindre NHS Trust, Cardiff, S Glam, Wales
[5] Univ Coll London Hosp, London, England
[6] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[7] Yeovil Dist Hosp, Yeovil, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps222
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS222
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Gemcitabine- or Capecitabine-based Chemoradiotherapy for localized advanced Pancreatic Cancer (SCALOP)
    Harrabi, S. B.
    Buechler, M. W.
    Werner, J.
    Combs, S. E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (03) : 319 - 320
  • [2] A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer
    Nakachi, Kohei
    Furuse, Junji
    Kinoshita, Taira
    Kawashima, Mitsuhiko
    Ishii, Hiroshi
    Ikeda, Masafumi
    Mitsunaga, Shuichi
    Shimizu, Satoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 527 - 534
  • [3] A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer
    Kohei Nakachi
    Junji Furuse
    Taira Kinoshita
    Mitsuhiko Kawashima
    Hiroshi Ishii
    Masafumi Ikeda
    Shuichi Mitsunaga
    Satoshi Shimizu
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 527 - 534
  • [4] Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer
    Jae-Sung Kim
    Joo Han Lim
    Jee Hyun Kim
    Seock-Ah Im
    Eui Kyu Chie
    Jin-Hyeok Hwang
    Tae-You Kim
    Yung-Jue Bang
    Sung Whan Ha
    Yong Bum Yoon
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 381 - 389
  • [5] Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer
    Kim, Jae-Sung
    Lim, Joo Han
    Kim, Jee Hyun
    Im, Seock-Ah
    Chie, Eui Kyu
    Hwang, Jin-Hyeok
    Kim, Tae-You
    Bang, Yung-Jue
    Ha, Sung Whan
    Yoon, Yong Bum
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (03) : 381 - 389
  • [6] Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer
    Kurt, Ender
    Kurt, Meral
    Kanat, Ozkan
    Cetintas, Sibel Kahraman
    Aygun, Sevilcan
    Palazoglu, Julay
    Ozkan, Lutfi
    Evrensel, Turkkan
    Kaya, Ekrem
    Manavoglu, Osman
    TUMORI, 2006, 92 (06) : 481 - 486
  • [7] Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial
    Mukherjee, Somnath
    Hurt, Christopher N.
    Bridgewater, John
    Falk, Stephen
    Cummins, Sebastian
    Wasan, Harpreet
    Crosby, Tom
    Jephcott, Catherine
    Roy, Rajarshi
    Radhakrishna, Ganesh
    McDonald, Alec
    Ray, Ruby
    Joseph, George
    Staffurth, John
    Abrams, Ross A.
    Griffiths, Gareth
    Maughan, Tim
    LANCET ONCOLOGY, 2013, 14 (04): : 317 - 326
  • [8] Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
    C N Hurt
    S Falk
    T Crosby
    A McDonald
    R Ray
    G Joseph
    J Staffurth
    R A Abrams
    G Griffiths
    T Maughan
    S Mukherjee
    British Journal of Cancer, 2017, 116 : 1264 - 1270
  • [9] Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
    Hurt, C. N.
    Falk, S.
    Crosby, T.
    McDonald, A.
    Ray, R.
    Joseph, G.
    Staffurth, J.
    Abrams, R. A.
    Griffiths, G.
    Maughan, T.
    Mukherjee, S.
    BRITISH JOURNAL OF CANCER, 2017, 116 (10) : 1264 - 1270
  • [10] Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer
    Michele Fiore
    Sara Ramella
    Sergio Valeri
    Damiano Caputo
    Barnaba Floreno
    Pasquale Trecca
    Luca Eolo Trodella
    Lucio Trodella
    Rolando Maria D’Angelillo
    Roberto Coppola
    Scientific Reports, 7
12345